Sebastian M. Real
Mendoza, M, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Rewriting nuclear epigenetic scripts in mitochondrial diseases as a strategy for heteroplasmy control.
Journal: EMBO molecular medicine
Published: April 01, 2025
Tessaria absinthioides (Hook. & Arn.) DC. Determines Inhibition of Tumor Growth and Metastasis In Vitro and In Vivo in Murine Melanoma.
Journal: Plants (Basel, Switzerland)
Published: March 19, 2025
Exploring ID4 as a driver of aggression and a therapeutic target in triple-negative breast cancer.
Journal: NPJ breast cancer
Published: February 14, 2025
Rewriting nuclear epigenetic scripts in mitochondrial diseases as a strategy for heteroplasmy control.
Journal: bioRxiv : the preprint server for biology
Published: January 13, 2025
Exploring the epigenetic profile of ID4 in breast cancer: bioinformatic insights into methylation patterns and chromatin accessibility dynamics.
Journal: Breast cancer research and treatment
Published: January 11, 2024
The Yin and Yang of Breast Cancer: Ion Channels as Determinants of Left-Right Functional Differences.
Journal: International journal of molecular sciences
Published: May 11, 2023
Correction to: When left does not seem right: epigenetic and bioelectric differences between left and right‑sided breast cancer.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 01, 2022
When left does not seem right: epigenetic and bioelectric differences between left- and right-sided breast cancer.
Journal: Molecular medicine (Cambridge, Mass.)
Published: October 26, 2021
CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors.
Journal: Breast cancer (Tokyo, Japan)
Published: April 21, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026